Literature DB >> 9120018

Monocytes and tissue factor promote thrombosis in a murine model of oxygen deprivation.

C A Lawson1, S D Yan, S F Yan, H Liao, Y S Zhou, J Sobel, W Kisiel, D M Stern, D J Pinsky.   

Abstract

Clinical conditions associated with local or systemic hypoxemia can lead to prothrombotic diatheses. This study was undertaken to establish a model of whole-animal hypoxia wherein oxygen deprivation by itself would be sufficient to trigger tissue thrombosis. Furthermore, this model was used to test the hypothesis that hypoxia-induced mononuclear phagocyte (MP) recruitment and tissue factor (TF) expression may trigger the local deposition of fibrin which occurs in response to oxygen deprivation. Using an environmental chamber in which inhaled oxygen tension was lowered to 6%, hypoxic induction of thrombosis was demonstrated in murine pulmonary vasculature by 8 h based upon: (a) immunohistologic evidence of fibrin formation in hypoxic lung tissue using an antifibrin antibody, confirmed by 22.5-nm strand periodicity by electron microscopy; (b) immunoblots revealing fibrin gamma-gamma chain dimers in lungs from hypoxic but not normoxic mice or hypoxic mice treated with hirudin; (c) accelerated deposition of 125I-fibrin/fibrinogen and 111In-labeled platelets in the lung tissue of hypoxic compared with normoxic animals; (d) reduction of tissue 125I-fibrin/fibrinogen accumulation in animals which had either been treated with hirudin or depleted of platelets before hypoxic exposure. Because immunohistochemical analysis of hypoxic pulmonary tissue revealed strong MP staining for TF, confirmed by increased TF RNA in hypoxic lungs, and because 111In-labeled murine MPs accumulated in hypoxic pulmonary tissue, we evaluated whether recruited MPs might be responsible for initiation of hypoxia-induced thrombosis. This hypothesis was supported by several lines of evidence: (a) MP depletion before hypoxia reduced thrombosis, as measured by reduced 125I-fibrin/fibrinogen deposition and reduced accumulation of cross-linked fibrin by immunoblot; (b) isolated murine MPs demonstrated increased TF immunostaining when exposed to hypoxia; and (c) administration of an anti-rabbit TF antibody that cross-reacts with murine TF decreased 125I-fibrin/fibrinogen accumulation and cross-linked fibrin accumulation in response to hypoxia in vivo. In summary, these studies using a novel in vivo model suggest that MP accumulation and TF expression may promote hypoxia-induced thrombosis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9120018      PMCID: PMC507994          DOI: 10.1172/JCI119337

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  41 in total

1.  Biological activities of tritiated endotoxins: correlation of the Limulus lysate assay with rabbit pyrogen and complement-activation assays for endotoxin.

Authors:  P A Tomasulo; J Levin; P A Murphy; J A Winkelstein
Journal:  J Lab Clin Med       Date:  1977-02

2.  Development of an immunoassay for the COOH-terminal region of the gamma chains of human fibrin.

Authors:  B Lahiri; J A Koehn; R E Canfield; S Birken; J Lewis
Journal:  Thromb Res       Date:  1981 Jul 1-15       Impact factor: 3.944

3.  Plasmic degradation of crosslinked fibrin. I. Structural analysis of the particulate clot and identification of new macromolecular-soluble complexes.

Authors:  C W Francis; V J Marder; S E Martin
Journal:  Blood       Date:  1980-09       Impact factor: 22.113

4.  Electrical induction of coronary artery thrombosis in the ambulatory canine: a model for in vivo evaluation of anti-thrombotic agents.

Authors:  J L Romson; D W Haack; B R Lucchesi
Journal:  Thromb Res       Date:  1980-03-15       Impact factor: 3.944

5.  The PO2 in venous valve pockets: its possible bearing on thrombogenesis.

Authors:  J D Hamer; P C Malone; I A Silver
Journal:  Br J Surg       Date:  1981-03       Impact factor: 6.939

6.  The sequestration and margination of platelets and leucocytes in veins during conditions of hypokinetic and anaemic hypoxia: potential significance in clinical postoperative venous thrombosis.

Authors:  P C Malone; C J Morris
Journal:  J Pathol       Date:  1978-07       Impact factor: 7.996

7.  Mononuclear cell tissue factor: cell of origin and requirements for activation.

Authors:  R L Edwards; F R Rickles; A M Bobrove
Journal:  Blood       Date:  1979-08       Impact factor: 22.113

8.  Oxygen tension regulates the expression of angiogenesis factor by macrophages.

Authors:  D R Knighton; T K Hunt; H Scheuenstuhl; B J Halliday; Z Werb; M J Banda
Journal:  Science       Date:  1983-09-23       Impact factor: 47.728

9.  Pharmacokinetics, biodistribution and tumor localization of two anti-human B-cell chronic lymphocytic leukemia monoclonal antibodies and their F(ab)'2 fragments in a xenograft model.

Authors:  Z Zhu; T Ghose; S Iles; C Yang; S H Lee; L A Fernandez; C L Lee
Journal:  Cancer Lett       Date:  1994-01-15       Impact factor: 8.679

10.  Immunoenzyme histochemical localization of fibrin degradation products in tissues.

Authors:  J J Emeis; J Lindeman; W Nieuwenhuizen
Journal:  Am J Pathol       Date:  1981-06       Impact factor: 4.307

View more
  37 in total

1.  Normal levels of anticoagulant heparan sulfate are not essential for normal hemostasis.

Authors:  Sassan HajMohammadi; Keiichi Enjyoji; Marc Princivalle; Patricia Christi; Miroslav Lech; David Beeler; Helen Rayburn; John J Schwartz; Samad Barzegar; Ariane I de Agostini; Mark J Post; Robert D Rosenberg; Nicholas W Shworak
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

2.  Egr-1: is it always immediate and early?

Authors:  S F Yan; D J Pinsky; N Mackman; D M Stern
Journal:  J Clin Invest       Date:  2000-03       Impact factor: 14.808

Review 3.  High altitude hypoxia: an intricate interplay of oxygen responsive macroevents and micromolecules.

Authors:  S Sarkar; P K Banerjee; W Selvamurthy
Journal:  Mol Cell Biochem       Date:  2003-11       Impact factor: 3.396

4.  Targeted expression of heme oxygenase-1 prevents the pulmonary inflammatory and vascular responses to hypoxia.

Authors:  T Minamino; H Christou; C M Hsieh; Y Liu; V Dhawan; N G Abraham; M A Perrella; S A Mitsialis; S Kourembanas
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-10       Impact factor: 11.205

5.  A synthetic selective inhibitor of factor Xa, DX-9065a, reduces monocyte chemoattractant protein-1 expression after ischemia-reperfusion injury in rat liver.

Authors:  Y Yamaguchi; K Okabe; J Liang; F Matsumura; H Ohshiro; K Ishihara; T Matsuda; M Takeya; J I Kuratsu; K Mori; S Yamada; M Ogawa
Journal:  Dig Dis Sci       Date:  1999-12       Impact factor: 3.199

6.  cAMP/CREB-mediated transcriptional regulation of ectonucleoside triphosphate diphosphohydrolase 1 (CD39) expression.

Authors:  Hui Liao; Matthew C Hyman; Amy E Baek; Keigo Fukase; David J Pinsky
Journal:  J Biol Chem       Date:  2010-02-23       Impact factor: 5.157

Review 7.  Early and innovative interventions for severe sepsis and septic shock: taking advantage of a window of opportunity.

Authors:  Emanuel P Rivers; Lauralyn McIntyre; David C Morro; Kandis K Rivers
Journal:  CMAJ       Date:  2005-10-25       Impact factor: 8.262

8.  Inhibit the calpain to climb the mountain.

Authors:  Rafal Pawlinski
Journal:  Blood       Date:  2014-02-20       Impact factor: 22.113

Review 9.  Mice deficient in heparan sulfate 3-O-sulfotransferase-1: normal hemostasis with unexpected perinatal phenotypes.

Authors:  Nicholas W Shworak; Sassan HajMohammadi; Ariane I de Agostini; Robert D Rosenberg
Journal:  Glycoconj J       Date:  2002 May-Jun       Impact factor: 2.916

10.  Coordinated induction of plasminogen activator inhibitor-1 (PAI-1) and inhibition of plasminogen activator gene expression by hypoxia promotes pulmonary vascular fibrin deposition.

Authors:  D J Pinsky; H Liao; C A Lawson; S F Yan; J Chen; P Carmeliet; D J Loskutoff; D M Stern
Journal:  J Clin Invest       Date:  1998-09-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.